NVAX
Novavax Inc
10.10$
+1.1%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +18.2% | -57.6% | +103.1% | +10.0% | -45.6% | +2,448.5% | +141.0% | +39.5% | -65.2% | +22.6% | +64.7% | |
| – | +985.2% | +46.3% | -29.2% | +3.2% | -34.5% | +556.2% | -98.3% | +7,029.3% | -61.9% | -41.0% | -64.9% | |
| – | -906.5% | – | – | +10.0% | -377.6% | – | +141.0% | -39.3% | -69.5% | +125.5% | +119.5% | |
| – | +104.8% | +46.3% | -29.2% | +3.2% | -34.5% | +556.2% | +239.3% | -51.3% | -40.3% | -47.0% | -13.9% | |
| – | +54.8% | +50.9% | -26.0% | -0.1% | +0.0% | +322.1% | +105.4% | +63.8% | -2.7% | -29.1% | -53.3% | |
| – | +94.7% | +47.0% | -28.7% | +2.6% | -28.8% | +501.9% | +217.5% | -52.7% | -41.9% | -6.5% | -32.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +53.5% | +5,279.7% | +8.5% | -13.4% | +11.7% | +11.3% | +39.5% | -5.9% | -27.5% | +39.3% | +12.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -0.3% | -41.2% | -290.9% | – | +216.0% | -85.3% | -52.7% | +435.9% | -82.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.